Imaging in 2020
program
2020

 

Imaging Theragnostics

  Timothy McCarthy, PhD
Pfizer Global R&D
The promises and realities of imaging as a biomarker to accelerate drug development
  Andrew Raubitschek, MD
Beckman Research Institute,
City of Hope
Multimodal antibody imaging of prostate cancer
     
Horizons of Hyperpolarization
  Mark Conradi, PhD
Washington University
Diffusion-MRI of lungs and emphysema with hyperpolarized Helium-3
  John Kurhanewicz, PhD
UCSF
Hyperpolarized C-13 metabolic probes for the detection and characterization of prostate cancer prior to and after therapy
  Matthew Merritt, PhD
UT - Southwestern
Can hyperpolarized carbon be used for quantitative metabolic flux measurements?
  Elena Vinogradov, PhD
Beth Israel Deaconess
Recent advances with PHIP
     
Targeting the Cell Surface
  Victor Hruby, PhD
University of Arizona
Design, synthesis and biological evaluation of novel multimeric, heterovalent ligands for the detection and treatment of cancer
  Julie Sutcliffe, PhD
UC - Davis
Targeted molecular imaging using radiolabeled peptides: A random and rational approach
     
Quantitative Image Analysis
  Simon Warfield, PhD
Children's Hospital Boston
Algorithms for quantitative assessment of pediatric brain MRI
  David Wilson, PhD
Case Western Reserve
Cryo-imaging of whole mice and counting single fluorescently labeled cells
     
Chemistry of Optically Active Proteins
  Robert Campbell, PhD
University of Alberta
Chemistries of fluorescent proteins for in vivo sensing
  Al Rehemtulla, PhD
University of Michigan
Novel insights into cancer biology using molecular imaging reporters
     
Photoacoustics, Ultrasound & Optical
  Martin Fischer , PhD
Duke University
 
  Stuart Foster, PhD
Sunnybrook HSC
Microultrasound in the land of bioresearch
  Thomas Nelson, PhD
UCSD
Ultrasound beyond imaging
     
Activatable Agents
  Marty Pagel, PhD
Case Western Reserve
PARACEST MRI contrast agents that detect enzyme activities
  Lon Wilson, PhD
Rice University
MRI-guided cancer therapy: Gadolinium-encapsulated carbon nanostructures for theragnostics
     
New Chemistries for Contrast Agents
  Bob Lenkinski, PhD
Beth Israel Deaconess
Advances in PARACEST MR imaging
  David Parker, DPhil, FRS
Durham University
Engineering emissive europium complexes for imaging and sensing
     
Imaging Hypoxia
  Murali C. Krishna, PhD
National Cancer Institute
Low field MR imaging of tumor pO2
  Kenneth A. Krohn, PhD
University of Washington
Testing the clinical implications of hypoxia imaging
     
 

 

HOMECONFERENCE CONTACTSPROGRAMREGISTRATIONPOSTERS & ABSTRACTSAGENDAACTIVITIESLODGINGTRAVELSPONSORS2005 MEETING